The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory ...

The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory ...

Objective: To test the hypothesis that once-daily treatment with fluticasone propionate is as effective as twice-daily treatment in children with well controlled asthma. Design: Multicentre ...

Use this medication on the skin only. However, do not use it on the face, groin, or underarms, or for diaper rash, unless directed to do so by your doctor. Wash and dry your hands before using.

The extended-release fluticasone propionate injection (EP-104IAR ... support the possibility of bilateral and repeat dosing.” The study’s generalizability may be limited due to the ...

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology to optimize drug delivery for applications with significant unmet need, ...

In the INS class, fluticasone propionate (Flonase ... the package insert indication specifies treatment of symptoms of seasonal and perennial allergic rhinitis, rather than focusing specifically ...

Despite twice-daily dosing of PPIs, reflux symptoms can ... with eosinophilic esophagitis with inhaled steroids (e.g. fluticasone propionate twice daily [morning and evening]) for up to 3 months ...

There are many types of asthma inhalers. They differ in whether they're used for quick relief or long-term control, what type ...

The publication is titled, "Efficacy and safety of a novel extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis: a randomized, vehicle-controlled ...

The publication is titled, "Efficacy and safety of a novel extended-release fluticasone propionate intra-articular ... The potential uses in therapeutic areas may go beyond pain and inflammatory ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology ...